Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
14 Leser
Artikel bewerten:
(0)

Orthobiologics Market Growing at 6.7% CAGR to 2019: Orthobiologics Product and End-User Analysis

DALLAS, May 21, 2015 /PRNewswire/ --

The Orthobiologics Market by Product (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Orthopedic Clinics) - Global Forecast to 2019 research report forecasts a 6.7% CAGR growth from 2014 to 2019.

Complete report on orthobiologics market spread across 99 pages, providing analysis of 11 major companies and supported with 42 tables and 63 figures is now available at http://www.rnrmarketresearch.com/orthobiologics-market-by-product-bone-allograft-bone-graft-substitutes-bone-growth-factors-spinal-stimulation-stem-cell-therapy-viscosupplementation-by-end-user-hospitals-orthopedic-clinics-market-report.html .

The end-user segment of orthobiologics market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers and acquisitions in order to establish their position in this highly competitive market.

The report has profiled leading players of orthobiologics market along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Major players of the global orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.). Order a copy of this research at http://www.rnrmarketresearch.com/contacts/purchase?rname=374046 .

This comprehensive orthobiologics market research report has focused on various levels of analysis:-industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which constitute basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the orthobiologics market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to verify the current orthobiologics market conditions which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a customized combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

This orthobiologics market report provides insights on the following pointers:

Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the orthobiologics market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.

OrthobiologicsMarket Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for orthobiologics across geographies so as to exploit new clientele base and different pricing policies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market.

Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players in order to enhance the bottom line of the companies in the orthobiologics market.

Product/ Brand Perception Analysis: Comprehensive study of customer perception and behavior through our inbuilt social connect tools (digital marketing language) and checking the tenacity of blogs and social forums.

On the same lines, another research on North American orthobiologics market forecasts the orthobiologics market in North America to grow at a CAGR of 7.7% from 2014 to 2019 with North America being the highest contributor of the global orthobiologics market. The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market. In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers. Read more on the North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing)-Analysis and Forecast to 2019 research report at http://www.rnrmarketresearch.com/north-american-orthobiologics-market-by-type-bone-allograft-bone-graft-substitutes-bone-growth-factors-spinal-stimulation-stem-cell-therapy-viscosupplementation-by-end-user-hospitals-point-market-report.html .

The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America. Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. The companies operating in this region have been focusing on new product developments, mergers and acquisitions in order to establish their position in this highly competitive and rapidly growing market.

Explore more reports on the medical devices market at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus:https://plus.google.com/104156468549256253075/posts

Twitter:https://twitter.com/RnRMR

Facebook:https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds:http://www.rnrmarketresearch.com/feed

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@rnrmarketresearch.com


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.